boston university medical center

Comparison of effects of red wine versus white wine on hormones ...

EurekAlert! - Cancer  Wed, 01/18/2012 - 23:00

(Boston University Medical Center) Aromatase inhibitors prevent the conversion of androgens to estrogens, and could play a role in the development of breast cancer.

This study of 36 pre-menopausal women consisted of a cross-over intervention trial to determine if there were differences between red wine and white wine in their effects on AIs.


 

BUSM researchers identify novel compound to halt virus replicati...

EurekAlert! - Infectious and Emerging Diseases  Mon, 01/02/2012 - 23:00

(Boston University Medical Center) BUSM researchers identify novel compound to halt virus replication.


 

BUSM researcher awarded 2 NIH grants totaling over $11 million

EurekAlert! - Infectious and Emerging Diseases  Tue, 11/01/2011 - 22:00

(Boston University Medical Center) Boston University School of Medicine researcher Robert Lafyatis, M.D., recently was awarded two grants from the National Institutes of Health's National Institute of Arthritis and Musculoskeletal and Skin Diseases.


 

BMC selected spinal cord injury model system site by NIDRR

EurekAlert! - Medicine and Health  Wed, 10/26/2011 - 22:00

(Boston University Medical Center) The New England Regional Spinal Cord Injury Center at Boston Medical Center has been selected as a Spinal Cord Injury Model System by the National Institute on Disability and Rehabilitation Research.


 

Physician honored for medical contributions in US and Armenia

EurekAlert! - Cancer  Wed, 10/19/2011 - 22:00

(Boston University Medical Center) Richard Babayan, M.D., was honored recently by the Armenian American Health Professional Organization for his exceptional contributions to medicine in both the United States and in Armenia.

The award was presented by Dr. Aram Chobanian, former dean of Boston University School of Medicine and president of Boston University.

Babayan serves as a professor and chairman of the department of urology at BUSM and chief of urology at Boston Medical Center.


 

Researchers from Boston University receive grant to develop impr...

EurekAlert! - Infectious and Emerging Diseases  Mon, 10/03/2011 - 22:00

(Boston University Medical Center) A team of researchers from Boston University's School of Medicine and College of Engineering have been awarded a five-year, $4.8 million National Institutes of Health grant to develop a low-cost, multiplexed virus detection platform.

Based on technologies developed with seed funding from Boston University's Photonics Center, the resulting diagnostic platform should be capable of rapidly detecting -- at the point of care -- viral pathogens such as Ebola, Lassa fever and Marburg.


 

Study finds aggressive glycemic control in diabetic cabg patient...

EurekAlert! - Medicine and Health  Mon, 09/26/2011 - 22:00

(Boston University Medical Center) Study finds aggressive glycemic control in diabetic cabg patients does not improve survival.


 

Study shows answers for treating obesity-related diseases may re...

EurekAlert! - Medicine and Health  Sun, 07/03/2011 - 22:00

(Boston University Medical Center) Researchers at Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) have shown that the quality -- not just the quantity -- of adipose, or fat, tissue is a significant contributing factor in the development of inflammation and vascular disease in obese individuals.


 

BMC conducts high rates of thyroid testing in pregnant women, st...

EurekAlert! - Medicine and Health  Wed, 06/29/2011 - 22:00

(Boston University Medical Center) A recent study completed by researchers from Boston University School of Medicine and Boston Medical Center (BMC) demonstrates that BMC conducts a high rate of thyroid function testing in pregnant women.


 

BUSM study identifies new potential approaches to treat myelofib...

EurekAlert! - Cancer  Wed, 06/22/2011 - 22:00

(Boston University Medical Center) A new study conducted by a team of researchers at Boston University School of Medicine sheds light on a possible new approach to treat the bone marrow disease known as myelofibrosis by inhibiting an enzyme that connects extracellular fibers.